This service is more advanced with JavaScript available, learn more at http://activatejavascript.org

Reactions Weekly

January 2017, Volume 1633, Issue 1, pp 178–178 | Cite as

Ceritinib/crizotinib

Development of drug resistance: case report

Case report

First Online: 07 January 2017

14 Downloads

This is a preview of subscription content, to check access.

Reference

Levacq D, et al. Histological transformation of ALK rearranged adenocarcinoma into small cell lung cancer: A new mechanism of resistance to ALK inhibitors. Lung Cancer 102: 38-41, Dec 2016. Available from: URL: http://doi.org/10.1016/j.lungcan.2016.10.012 - BelgiumCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

About this article

Cite this article as:: Reactions Weekly (2017) 1633: 178. https://doi.org/10.1007/s40278-017-24448-5

DOI https://doi.org/10.1007/s40278-017-24448-5
Publisher Name Springer International Publishing
Print ISSN 0114-9954
Online ISSN 1179-2051

Published in cooperation with
Adis

Personalised recommendations